Featured news in The Life Sciences Report



RepliCel Life Sciences Inc. (RP:TSX.V; REPCF:OTCQB)
RepliCel Life Sciences Announces Signed Licensing and Co-Development Deal for Greater China (7/11/2018)

view
 


Celgene Corp. (CELG:NASDAQ)
Today's Research Reports on Trending Tickers: Galapagos and Celgene (7/11/2018)

view
 

Celgene Corp. (CELG:NASDAQ)
Biotech Stock Roundup: BIIB's Gain on Alzheimer's Data, Regulatory Updates & More (7/11/2018)

view
 

Celgene Corp. (CELG:NASDAQ)
Drug Developers Expecting Significant Clinical and Economic Benefits by Targeting Newest Drug Therapies (7/11/2018)

view
 


Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Leading Commercial and Transactional Healthcare Executive Shawn Cline Tomasello Joins Mesoblast Board (7/11/2018)

view
 


Sproutly Canada Inc. (SPR:CSE;SRUTF:OTCQB)
IIROC Trading Halt - SO (2/8/2018)

view
 


ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB)
ProMIS Neurosciences to Present Preclinical Data on Alzheimer's Disease Therapeutic Antibody PMN310 at Alzheimer's Association International Conference (7/10/2018)

view
 


Sproutly Canada Inc. (SPR:CSE;SRUTF:OTCQB)
Stone Ridge Exploration reaches new 52-Week High (1/22/2018)

view
 

Sproutly Canada Inc. (SPR:CSE;SRUTF:OTCQB)
Stone Ridge Provides Update on RTO: Sproutly is Granted an ACMPR license to cultivate cannabis from Health Canada (6/14/2018)

view
 

Sproutly Canada Inc. (SPR:CSE;SRUTF:OTCQB)
New Cannabis Listing, Game-Changing Technology, BIG Opportunity (7/9/2018)

view
 

Sproutly Canada Inc. (SPR:CSE;SRUTF:OTCQB)
Stone Ride Provides Update on RTO: Sproutly is Granted an ACMPR license to cultivate cannabis from Health Canada (6/14/2018)

view
 

Sproutly Canada Inc. (SPR:CSE;SRUTF:OTCQB)
Sproutly Canada Inc. reaches new 52-Week High (7/9/2018)

view
 

Sproutly Canada Inc. (SPR:CSE;SRUTF:OTCQB)
CSE New Listing - Sproutly Canada Inc. Commences Trading on the Canadian Securities Exchange - Video News Alert on InvestmentPitch.com (7/10/2018)

view
 


Celgene Corp. (CELG:NASDAQ)
CTI BioPharma Falls After Failure of Pivotal Lymphoma Study (7/10/2018)

view
 

Celgene Corp. (CELG:NASDAQ)
Biotech ETFs Surge on Biogen's Positive Drug Trial Result (7/9/2018)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
Hynes Keller & Hernandez, LLC Announces Investigation of MiMedx Group, Inc. (MDXG) (7/10/2018)

view
 


DURECT Corp. (DRRX:NASDAQ)
Complimentary Technical Snapshots on Teva Pharma Industries and Three More Drug Makers Stocks (7/9/2018)

view
 


Amarantus BioScience Holdings Inc. (AMBS:OTCQB)
MANF Therapeutics Announces Positive MANF Pre-Clinical Data inAlpha-Synuclein Model of Parkinson's DiseasePublished in Peer-Reviewed Journal Experimental Neurobiology (7/9/2018)

view